Showing results (11-20 of 246) with videos related to

Sort By:
Pageof 25
European Journal of Immunology|May 22, 2008
Human CD4(+) T cells maintain specific functions even under conditions of extremely restricted ATP productionRobert Tripmacher, Timo Gaber, René Dziurla, et al.
Arthritis Research & Therapy|February 14, 2006
Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control studyBerthold Hoppe, Thomas Häupl, Rudolf Gruber, et al.
Lancet (London, England)|March 1, 2005
Optimised glucocorticoid therapy: the sharpening of an old spearFrank Buttgereit, Gerd-Rüdiger Burmester, Brian J Lipworth
Zeitschrift Fur Rheumatologie|September 1, 2023
[Therapeutic antibodies in rheumatology]Fredrik N Albach, Gerd-Rüdiger Burmester, Johanna Mucke
Therapeutic Advances in Musculoskeletal Disease|October 18, 2021
The role of upadacitinib in the treatment of moderate-to-severe active rheumatoid arthritisAli Berkant Avci, Eugen Feist, Gerd Rüdiger Burmester
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 30, 2018
Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What's the Difference?Ali Berkant Avci, Eugen Feist, Gerd Rüdiger Burmester
Clinical and Experimental Rheumatology|September 3, 2016
Targeting GM-CSF in rheumatoid arthritisAli Berkant Avci, Eugen Feist, Gerd-Rüdiger Burmester
Deutsches Arzteblatt International|December 17, 2021
The Safety of Antirheumatic DrugsJohanna Mucke, Hans-Uwe Simon, Gerd Rüdiger Burmester
Rheumatology (Oxford, England)|May 5, 2021
Early phase studies of JAK1 selective inhibitors in rheumatoid arthritisAli Berkant Avci, Eugen Feist, Gerd Rüdiger Burmester
Die Naturwissenschaften|November 19, 2002
Stem cells for regenerative medicine: advances in the engineering of tissues and organsJochen Ringe, Christian Kaps, Gerd-Rüdiger Burmester, et al.
Pageof 25